nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—SLC22A8—Liothyronine—hypothyroidism	0.184	0.267	CbGbCtD
Furosemide—SLC22A8—Liotrix—hypothyroidism	0.18	0.261	CbGbCtD
Furosemide—ALB—Levothyroxine—hypothyroidism	0.109	0.159	CbGbCtD
Furosemide—ALB—Liothyronine—hypothyroidism	0.109	0.159	CbGbCtD
Furosemide—ALB—Liotrix—hypothyroidism	0.107	0.155	CbGbCtD
Furosemide—Metabolic alkalosis—Liotrix—hypothyroidism	0.0176	0.107	CcSEcCtD
Furosemide—Nephrocalcinosis—Liotrix—hypothyroidism	0.0148	0.0897	CcSEcCtD
Furosemide—SLC12A1—urine—hypothyroidism	0.00819	0.0742	CbGeAlD
Furosemide—Tetany—Liotrix—hypothyroidism	0.00785	0.0478	CcSEcCtD
Furosemide—Gastric irritation—Liotrix—hypothyroidism	0.0066	0.0401	CcSEcCtD
Furosemide—Abdominal bloating—Liotrix—hypothyroidism	0.00537	0.0327	CcSEcCtD
Furosemide—Epigastric discomfort—Liotrix—hypothyroidism	0.00487	0.0296	CcSEcCtD
Furosemide—SLC22A8—urine—hypothyroidism	0.00475	0.0431	CbGeAlD
Furosemide—CA1—nerve—hypothyroidism	0.00389	0.0352	CbGeAlD
Furosemide—SLCO2A1—Transport of organic anions—AVP—hypothyroidism	0.0034	0.0945	CbGpPWpGaD
Furosemide—Arrhythmia—Liothyronine—hypothyroidism	0.00318	0.0193	CcSEcCtD
Furosemide—CA4—nerve—hypothyroidism	0.00304	0.0275	CbGeAlD
Furosemide—Hypocalcaemia—Liotrix—hypothyroidism	0.0028	0.017	CcSEcCtD
Furosemide—CA5A—liver—hypothyroidism	0.00246	0.0223	CbGeAlD
Furosemide—Irritability—Dextrothyroxine—hypothyroidism	0.00241	0.0147	CcSEcCtD
Furosemide—Irritability—Levothyroxine—hypothyroidism	0.00241	0.0147	CcSEcCtD
Furosemide—Hypotension—Liothyronine—hypothyroidism	0.00236	0.0144	CcSEcCtD
Furosemide—Dehydration—Dextrothyroxine—hypothyroidism	0.00235	0.0143	CcSEcCtD
Furosemide—Dehydration—Levothyroxine—hypothyroidism	0.00235	0.0143	CcSEcCtD
Furosemide—CA14—heart—hypothyroidism	0.00234	0.0212	CbGeAlD
Furosemide—Lightheadedness—Liotrix—hypothyroidism	0.00229	0.0139	CcSEcCtD
Furosemide—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00223	0.0135	CcSEcCtD
Furosemide—Muscular weakness—Levothyroxine—hypothyroidism	0.00223	0.0135	CcSEcCtD
Furosemide—Swelling—Liotrix—hypothyroidism	0.00211	0.0128	CcSEcCtD
Furosemide—SLCO2A1—adrenal cortex—hypothyroidism	0.002	0.0181	CbGeAlD
Furosemide—Body temperature increased—Liothyronine—hypothyroidism	0.002	0.0122	CcSEcCtD
Furosemide—SLCO2A1—heart—hypothyroidism	0.00194	0.0175	CbGeAlD
Furosemide—Sweating—Levothyroxine—hypothyroidism	0.00187	0.0113	CcSEcCtD
Furosemide—Sweating—Dextrothyroxine—hypothyroidism	0.00187	0.0113	CcSEcCtD
Furosemide—PGD—adrenal cortex—hypothyroidism	0.00178	0.0162	CbGeAlD
Furosemide—Irritability—Liotrix—hypothyroidism	0.00177	0.0108	CcSEcCtD
Furosemide—CA14—adrenal gland—hypothyroidism	0.00174	0.0158	CbGeAlD
Furosemide—Blood creatinine increased—Liotrix—hypothyroidism	0.00174	0.0106	CcSEcCtD
Furosemide—Dehydration—Liotrix—hypothyroidism	0.00173	0.0105	CcSEcCtD
Furosemide—PGD—heart—hypothyroidism	0.00173	0.0156	CbGeAlD
Furosemide—Hypokalaemia—Liotrix—hypothyroidism	0.00169	0.0103	CcSEcCtD
Furosemide—Muscular weakness—Liotrix—hypothyroidism	0.00164	0.00996	CcSEcCtD
Furosemide—CA5B—heart—hypothyroidism	0.00164	0.0148	CbGeAlD
Furosemide—PGD—cardiovascular system—hypothyroidism	0.00163	0.0148	CbGeAlD
Furosemide—SLCO2A1—pituitary gland—hypothyroidism	0.00162	0.0147	CbGeAlD
Furosemide—Abdominal distension—Liotrix—hypothyroidism	0.00162	0.00983	CcSEcCtD
Furosemide—CA7—cerebellum—hypothyroidism	0.0016	0.0145	CbGeAlD
Furosemide—SLC12A1—blood—hypothyroidism	0.00157	0.0142	CbGeAlD
Furosemide—Arrhythmia—Levothyroxine—hypothyroidism	0.00156	0.00949	CcSEcCtD
Furosemide—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00156	0.00949	CcSEcCtD
Furosemide—CA5B—cardiovascular system—hypothyroidism	0.00154	0.014	CbGeAlD
Furosemide—CA9—testis—hypothyroidism	0.00152	0.0138	CbGeAlD
Furosemide—PGD—gonad—hypothyroidism	0.00148	0.0134	CbGeAlD
Furosemide—SLCO2A1—adrenal gland—hypothyroidism	0.00145	0.0131	CbGeAlD
Furosemide—CA1—heart—hypothyroidism	0.00144	0.0131	CbGeAlD
Furosemide—PGD—pituitary gland—hypothyroidism	0.00144	0.0131	CbGeAlD
Furosemide—Renal failure—Liotrix—hypothyroidism	0.00141	0.00856	CcSEcCtD
Furosemide—CA9—cerebellum—hypothyroidism	0.0014	0.0127	CbGeAlD
Furosemide—CA5B—gonad—hypothyroidism	0.0014	0.0127	CbGeAlD
Furosemide—Agitation—Levothyroxine—hypothyroidism	0.0014	0.0085	CcSEcCtD
Furosemide—Agitation—Dextrothyroxine—hypothyroidism	0.0014	0.0085	CcSEcCtD
Furosemide—SLCO2A1—thyroid gland—hypothyroidism	0.00139	0.0126	CbGeAlD
Furosemide—Sweating—Liotrix—hypothyroidism	0.00137	0.00835	CcSEcCtD
Furosemide—CA14—liver—hypothyroidism	0.00136	0.0124	CbGeAlD
Furosemide—CA1—cardiovascular system—hypothyroidism	0.00136	0.0123	CbGeAlD
Furosemide—SLCO2A1—female gonad—hypothyroidism	0.00135	0.0122	CbGeAlD
Furosemide—CA14—cerebellum—hypothyroidism	0.00133	0.0121	CbGeAlD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00133	0.037	CbGpPWpGaD
Furosemide—SLC12A1—testis—hypothyroidism	0.0013	0.0117	CbGeAlD
Furosemide—PGD—adrenal gland—hypothyroidism	0.00129	0.0117	CbGeAlD
Furosemide—PGD—blood—hypothyroidism	0.00129	0.0117	CbGeAlD
Furosemide—ALB—heart—hypothyroidism	0.00127	0.0115	CbGeAlD
Furosemide—SLCO2A1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.00126	0.0351	CbGpPWpGaD
Furosemide—SLC22A11—liver—hypothyroidism	0.00126	0.0114	CbGeAlD
Furosemide—Confusional state—Levothyroxine—hypothyroidism	0.00125	0.00761	CcSEcCtD
Furosemide—Confusional state—Dextrothyroxine—hypothyroidism	0.00125	0.00761	CcSEcCtD
Furosemide—PGD—NRF2 pathway—SLC5A7—hypothyroidism	0.00125	0.0347	CbGpPWpGaD
Furosemide—PGD—thyroid gland—hypothyroidism	0.00124	0.0113	CbGeAlD
Furosemide—Shock—Levothyroxine—hypothyroidism	0.00122	0.00743	CcSEcCtD
Furosemide—Shock—Dextrothyroxine—hypothyroidism	0.00122	0.00743	CcSEcCtD
Furosemide—CA5B—adrenal gland—hypothyroidism	0.00122	0.0111	CbGeAlD
Furosemide—CA5B—blood—hypothyroidism	0.00122	0.0111	CbGeAlD
Furosemide—PGD—female gonad—hypothyroidism	0.0012	0.0109	CbGeAlD
Furosemide—Hyperhidrosis—Levothyroxine—hypothyroidism	0.0012	0.0073	CcSEcCtD
Furosemide—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.0012	0.0073	CcSEcCtD
Furosemide—SLCO2A1—testis—hypothyroidism	0.0012	0.0108	CbGeAlD
Furosemide—CA5B—thyroid gland—hypothyroidism	0.00118	0.0107	CbGeAlD
Furosemide—Arrhythmia—Liotrix—hypothyroidism	0.00115	0.00698	CcSEcCtD
Furosemide—SLCO2A1—liver—hypothyroidism	0.00113	0.0102	CbGeAlD
Furosemide—CA4—heart—hypothyroidism	0.00113	0.0102	CbGeAlD
Furosemide—Flatulence—Liotrix—hypothyroidism	0.0011	0.0067	CcSEcCtD
Furosemide—Dysgeusia—Liotrix—hypothyroidism	0.0011	0.00666	CcSEcCtD
Furosemide—CA1—blood—hypothyroidism	0.00108	0.00976	CbGeAlD
Furosemide—Fatigue—Dextrothyroxine—hypothyroidism	0.00107	0.00651	CcSEcCtD
Furosemide—Fatigue—Levothyroxine—hypothyroidism	0.00107	0.00651	CcSEcCtD
Furosemide—PGD—testis—hypothyroidism	0.00107	0.00965	CbGeAlD
Furosemide—CA4—cardiovascular system—hypothyroidism	0.00107	0.00965	CbGeAlD
Furosemide—Vision blurred—Liotrix—hypothyroidism	0.00105	0.00641	CcSEcCtD
Furosemide—Agitation—Liotrix—hypothyroidism	0.00103	0.00625	CcSEcCtD
Furosemide—Feeling abnormal—Levothyroxine—hypothyroidism	0.00102	0.00622	CcSEcCtD
Furosemide—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00102	0.00622	CcSEcCtD
Furosemide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00101	0.00617	CcSEcCtD
Furosemide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00101	0.00617	CcSEcCtD
Furosemide—CA5B—testis—hypothyroidism	0.00101	0.00914	CbGeAlD
Furosemide—PGD—liver—hypothyroidism	0.00101	0.00912	CbGeAlD
Furosemide—Urticaria—Levothyroxine—hypothyroidism	0.000986	0.006	CcSEcCtD
Furosemide—Urticaria—Dextrothyroxine—hypothyroidism	0.000986	0.006	CcSEcCtD
Furosemide—PGD—cerebellum—hypothyroidism	0.000984	0.00891	CbGeAlD
Furosemide—Abdominal pain—Levothyroxine—hypothyroidism	0.000981	0.00597	CcSEcCtD
Furosemide—Body temperature increased—Levothyroxine—hypothyroidism	0.000981	0.00597	CcSEcCtD
Furosemide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000981	0.00597	CcSEcCtD
Furosemide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000981	0.00597	CcSEcCtD
Furosemide—CA2—adrenal cortex—hypothyroidism	0.000968	0.00876	CbGeAlD
Furosemide—SLC22A5—adrenal cortex—hypothyroidism	0.000952	0.00862	CbGeAlD
Furosemide—ALB—adrenal gland—hypothyroidism	0.000947	0.00857	CbGeAlD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000943	0.0262	CbGpPWpGaD
Furosemide—CA4—pituitary gland—hypothyroidism	0.000943	0.00854	CbGeAlD
Furosemide—CA2—heart—hypothyroidism	0.000936	0.00848	CbGeAlD
Furosemide—SLC22A5—heart—hypothyroidism	0.000921	0.00834	CbGeAlD
Furosemide—Confusional state—Liotrix—hypothyroidism	0.000921	0.0056	CcSEcCtD
Furosemide—Anaphylactic shock—Liotrix—hypothyroidism	0.000913	0.00555	CcSEcCtD
Furosemide—SLC22A8—blood—hypothyroidism	0.000909	0.00823	CbGeAlD
Furosemide—Shock—Liotrix—hypothyroidism	0.000898	0.00546	CcSEcCtD
Furosemide—Asthenia—Dextrothyroxine—hypothyroidism	0.000891	0.00542	CcSEcCtD
Furosemide—Asthenia—Levothyroxine—hypothyroidism	0.000891	0.00542	CcSEcCtD
Furosemide—ABCC2—adrenal gland—hypothyroidism	0.000887	0.00803	CbGeAlD
Furosemide—ABCC2—blood—hypothyroidism	0.000887	0.00803	CbGeAlD
Furosemide—CA2—cardiovascular system—hypothyroidism	0.000883	0.008	CbGeAlD
Furosemide—Hyperhidrosis—Liotrix—hypothyroidism	0.000883	0.00537	CcSEcCtD
Furosemide—Pruritus—Dextrothyroxine—hypothyroidism	0.000878	0.00534	CcSEcCtD
Furosemide—Pruritus—Levothyroxine—hypothyroidism	0.000878	0.00534	CcSEcCtD
Furosemide—Anorexia—Liotrix—hypothyroidism	0.00087	0.00529	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000861	0.0239	CbGpPWpGaD
Furosemide—Hypotension—Liotrix—hypothyroidism	0.000853	0.00519	CcSEcCtD
Furosemide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000849	0.00516	CcSEcCtD
Furosemide—Diarrhoea—Levothyroxine—hypothyroidism	0.000849	0.00516	CcSEcCtD
Furosemide—CA1—liver—hypothyroidism	0.000843	0.00763	CbGeAlD
Furosemide—CA4—adrenal gland—hypothyroidism	0.000842	0.00763	CbGeAlD
Furosemide—CA4—blood—hypothyroidism	0.000842	0.00763	CbGeAlD
Furosemide—Paraesthesia—Liotrix—hypothyroidism	0.00082	0.00499	CcSEcCtD
Furosemide—CA4—thyroid gland—hypothyroidism	0.000813	0.00736	CbGeAlD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000795	0.0221	CbGpPWpGaD
Furosemide—Decreased appetite—Liotrix—hypothyroidism	0.000794	0.00483	CcSEcCtD
Furosemide—Vomiting—Levothyroxine—hypothyroidism	0.000789	0.0048	CcSEcCtD
Furosemide—Vomiting—Dextrothyroxine—hypothyroidism	0.000789	0.0048	CcSEcCtD
Furosemide—Fatigue—Liotrix—hypothyroidism	0.000787	0.00479	CcSEcCtD
Furosemide—CA4—female gonad—hypothyroidism	0.000786	0.00711	CbGeAlD
Furosemide—ALB—testis—hypothyroidism	0.000783	0.00709	CbGeAlD
Furosemide—Rash—Levothyroxine—hypothyroidism	0.000783	0.00476	CcSEcCtD
Furosemide—Rash—Dextrothyroxine—hypothyroidism	0.000783	0.00476	CcSEcCtD
Furosemide—CA2—pituitary gland—hypothyroidism	0.000782	0.00708	CbGeAlD
Furosemide—Dermatitis—Levothyroxine—hypothyroidism	0.000782	0.00476	CcSEcCtD
Furosemide—Dermatitis—Dextrothyroxine—hypothyroidism	0.000782	0.00476	CcSEcCtD
Furosemide—Constipation—Liotrix—hypothyroidism	0.000781	0.00475	CcSEcCtD
Furosemide—Headache—Levothyroxine—hypothyroidism	0.000778	0.00473	CcSEcCtD
Furosemide—Headache—Dextrothyroxine—hypothyroidism	0.000778	0.00473	CcSEcCtD
Furosemide—SLC22A5—pituitary gland—hypothyroidism	0.000769	0.00697	CbGeAlD
Furosemide—Feeling abnormal—Liotrix—hypothyroidism	0.000752	0.00458	CcSEcCtD
Furosemide—Gastrointestinal pain—Liotrix—hypothyroidism	0.000747	0.00454	CcSEcCtD
Furosemide—ALB—liver—hypothyroidism	0.00074	0.0067	CbGeAlD
Furosemide—Nausea—Levothyroxine—hypothyroidism	0.000737	0.00448	CcSEcCtD
Furosemide—Nausea—Dextrothyroxine—hypothyroidism	0.000737	0.00448	CcSEcCtD
Furosemide—ABCC2—testis—hypothyroidism	0.000734	0.00664	CbGeAlD
Furosemide—Urticaria—Liotrix—hypothyroidism	0.000725	0.00441	CcSEcCtD
Furosemide—Abdominal pain—Liotrix—hypothyroidism	0.000722	0.00439	CcSEcCtD
Furosemide—Body temperature increased—Liotrix—hypothyroidism	0.000722	0.00439	CcSEcCtD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000719	0.02	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000718	0.02	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000713	0.0198	CbGpPWpGaD
Furosemide—CA2—adrenal gland—hypothyroidism	0.000699	0.00633	CbGeAlD
Furosemide—CA2—blood—hypothyroidism	0.000698	0.00632	CbGeAlD
Furosemide—CA4—testis—hypothyroidism	0.000697	0.00631	CbGeAlD
Furosemide—ABCC2—liver—hypothyroidism	0.000694	0.00628	CbGeAlD
Furosemide—SLC22A5—adrenal gland—hypothyroidism	0.000687	0.00622	CbGeAlD
Furosemide—SLC22A5—blood—hypothyroidism	0.000687	0.00622	CbGeAlD
Furosemide—CA2—thyroid gland—hypothyroidism	0.000674	0.0061	CbGeAlD
Furosemide—Hypersensitivity—Liotrix—hypothyroidism	0.000673	0.00409	CcSEcCtD
Furosemide—SLC22A5—thyroid gland—hypothyroidism	0.000663	0.00601	CbGeAlD
Furosemide—Asthenia—Liotrix—hypothyroidism	0.000655	0.00398	CcSEcCtD
Furosemide—CA2—female gonad—hypothyroidism	0.000651	0.0059	CbGeAlD
Furosemide—Pruritus—Liotrix—hypothyroidism	0.000646	0.00393	CcSEcCtD
Furosemide—CA4—cerebellum—hypothyroidism	0.000643	0.00583	CbGeAlD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.000643	0.0179	CbGpPWpGaD
Furosemide—SLC22A5—female gonad—hypothyroidism	0.000641	0.0058	CbGeAlD
Furosemide—Diarrhoea—Liotrix—hypothyroidism	0.000625	0.0038	CcSEcCtD
Furosemide—Dizziness—Liotrix—hypothyroidism	0.000604	0.00367	CcSEcCtD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.0006	0.0167	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000595	0.0165	CbGpPWpGaD
Furosemide—Vomiting—Liotrix—hypothyroidism	0.00058	0.00353	CcSEcCtD
Furosemide—CA2—testis—hypothyroidism	0.000578	0.00523	CbGeAlD
Furosemide—Rash—Liotrix—hypothyroidism	0.000576	0.0035	CcSEcCtD
Furosemide—Dermatitis—Liotrix—hypothyroidism	0.000575	0.0035	CcSEcCtD
Furosemide—Headache—Liotrix—hypothyroidism	0.000572	0.00348	CcSEcCtD
Furosemide—SLC22A5—testis—hypothyroidism	0.000568	0.00515	CbGeAlD
Furosemide—ALB—Transport of organic anions—AVP—hypothyroidism	0.00056	0.0156	CbGpPWpGaD
Furosemide—CA2—liver—hypothyroidism	0.000546	0.00495	CbGeAlD
Furosemide—Nausea—Liotrix—hypothyroidism	0.000542	0.0033	CcSEcCtD
Furosemide—SLC22A5—liver—hypothyroidism	0.000537	0.00487	CbGeAlD
Furosemide—CA2—cerebellum—hypothyroidism	0.000534	0.00483	CbGeAlD
Furosemide—SLC22A5—cerebellum—hypothyroidism	0.000525	0.00475	CbGeAlD
Furosemide—PGD—NRF2 pathway—SLC5A5—hypothyroidism	0.000499	0.0139	CbGpPWpGaD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000487	0.0135	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000437	0.0122	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000429	0.0119	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SLC5A7—hypothyroidism	0.000419	0.0117	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000365	0.0101	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000362	0.0101	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000361	0.01	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000355	0.00987	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000344	0.00956	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000327	0.00909	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000302	0.00841	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.0003	0.00832	CbGpPWpGaD
Furosemide—CA14—Metabolism—IYD—hypothyroidism	0.000288	0.00799	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000287	0.00798	CbGpPWpGaD
Furosemide—CA5A—Metabolism—IYD—hypothyroidism	0.00028	0.00779	CbGpPWpGaD
Furosemide—CA6—Metabolism—IYD—hypothyroidism	0.00028	0.00779	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000273	0.00758	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000271	0.00753	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000271	0.00753	CbGpPWpGaD
Furosemide—PGD—Metabolism—IYD—hypothyroidism	0.00027	0.00751	CbGpPWpGaD
Furosemide—CA7—Metabolism—IYD—hypothyroidism	0.000262	0.00727	CbGpPWpGaD
Furosemide—CA5B—Metabolism—IYD—hypothyroidism	0.000262	0.00727	CbGpPWpGaD
Furosemide—CA14—Metabolism—ATP5O—hypothyroidism	0.000244	0.00679	CbGpPWpGaD
Furosemide—CA12—Metabolism—IYD—hypothyroidism	0.000242	0.00674	CbGpPWpGaD
Furosemide—CA6—Metabolism—ATP5O—hypothyroidism	0.000238	0.00662	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ATP5O—hypothyroidism	0.000238	0.00662	CbGpPWpGaD
Furosemide—PGD—Metabolism—ATP5O—hypothyroidism	0.00023	0.00639	CbGpPWpGaD
Furosemide—CA14—Metabolism—TPO—hypothyroidism	0.00023	0.00639	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000226	0.00628	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000226	0.00628	CbGpPWpGaD
Furosemide—CA6—Metabolism—TPO—hypothyroidism	0.000224	0.00623	CbGpPWpGaD
Furosemide—CA5A—Metabolism—TPO—hypothyroidism	0.000224	0.00623	CbGpPWpGaD
Furosemide—CA7—Metabolism—ATP5O—hypothyroidism	0.000222	0.00618	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ATP5O—hypothyroidism	0.000222	0.00618	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000218	0.00605	CbGpPWpGaD
Furosemide—PGD—Metabolism—TPO—hypothyroidism	0.000216	0.00601	CbGpPWpGaD
Furosemide—CA7—Metabolism—TPO—hypothyroidism	0.000209	0.00581	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TPO—hypothyroidism	0.000209	0.00581	CbGpPWpGaD
Furosemide—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000208	0.00578	CbGpPWpGaD
Furosemide—CA12—Metabolism—ATP5O—hypothyroidism	0.000206	0.00573	CbGpPWpGaD
Furosemide—CA12—Metabolism—TPO—hypothyroidism	0.000194	0.00538	CbGpPWpGaD
Furosemide—CA4—Metabolism—IYD—hypothyroidism	0.000193	0.00537	CbGpPWpGaD
Furosemide—CA2—Metabolism—IYD—hypothyroidism	0.000185	0.00515	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000184	0.00511	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00018	0.00502	CbGpPWpGaD
Furosemide—CA1—Metabolism—IYD—hypothyroidism	0.000178	0.00494	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000175	0.00486	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000171	0.00476	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	0.000168	0.00466	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000166	0.00462	CbGpPWpGaD
Furosemide—CA4—Metabolism—ATP5O—hypothyroidism	0.000164	0.00457	CbGpPWpGaD
Furosemide—CA2—Metabolism—ATP5O—hypothyroidism	0.000158	0.00438	CbGpPWpGaD
Furosemide—CA9—Metabolism—IYD—hypothyroidism	0.000156	0.00434	CbGpPWpGaD
Furosemide—CA4—Metabolism—TPO—hypothyroidism	0.000154	0.00429	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000152	0.00423	CbGpPWpGaD
Furosemide—CA1—Metabolism—ATP5O—hypothyroidism	0.000151	0.0042	CbGpPWpGaD
Furosemide—CA2—Metabolism—TPO—hypothyroidism	0.000148	0.00412	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000146	0.00406	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000144	0.00402	CbGpPWpGaD
Furosemide—CA1—Metabolism—TPO—hypothyroidism	0.000142	0.00395	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000142	0.00394	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000139	0.00385	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000138	0.00383	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000138	0.00383	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000135	0.00375	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000134	0.00373	CbGpPWpGaD
Furosemide—CA9—Metabolism—ATP5O—hypothyroidism	0.000133	0.00369	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000131	0.00363	CbGpPWpGaD
Furosemide—CA9—Metabolism—TPO—hypothyroidism	0.000125	0.00347	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000118	0.00327	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000115	0.00319	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000115	0.00319	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000114	0.00316	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000111	0.00309	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000109	0.00303	CbGpPWpGaD
Furosemide—CA14—Metabolism—TSHB—hypothyroidism	0.000106	0.00296	CbGpPWpGaD
Furosemide—CA6—Metabolism—TSHB—hypothyroidism	0.000104	0.00288	CbGpPWpGaD
Furosemide—CA5A—Metabolism—TSHB—hypothyroidism	0.000104	0.00288	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000103	0.00286	CbGpPWpGaD
Furosemide—PGD—Metabolism—TSHB—hypothyroidism	0.0001	0.00278	CbGpPWpGaD
Furosemide—CA7—Metabolism—TSHB—hypothyroidism	9.68e-05	0.00269	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TSHB—hypothyroidism	9.68e-05	0.00269	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3C2A—hypothyroidism	9.48e-05	0.00264	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3C2A—hypothyroidism	9.24e-05	0.00257	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3C2A—hypothyroidism	9.24e-05	0.00257	CbGpPWpGaD
Furosemide—CA12—Metabolism—TSHB—hypothyroidism	8.97e-05	0.00249	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3C2A—hypothyroidism	8.92e-05	0.00248	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.71e-05	0.00242	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3C2A—hypothyroidism	8.63e-05	0.0024	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3C2A—hypothyroidism	8.63e-05	0.0024	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	8.59e-05	0.00239	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3C2A—hypothyroidism	7.99e-05	0.00222	CbGpPWpGaD
Furosemide—CA14—Metabolism—SLC5A5—hypothyroidism	7.97e-05	0.00221	CbGpPWpGaD
Furosemide—PGD—Disease—PRL—hypothyroidism	7.9e-05	0.0022	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SLC5A5—hypothyroidism	7.76e-05	0.00216	CbGpPWpGaD
Furosemide—CA6—Metabolism—SLC5A5—hypothyroidism	7.76e-05	0.00216	CbGpPWpGaD
Furosemide—PGD—Metabolism—SLC5A5—hypothyroidism	7.49e-05	0.00208	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.34e-05	0.00204	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—IGF1—hypothyroidism	7.32e-05	0.00204	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SLC5A5—hypothyroidism	7.25e-05	0.00201	CbGpPWpGaD
Furosemide—CA7—Metabolism—SLC5A5—hypothyroidism	7.25e-05	0.00201	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.21e-05	0.002	CbGpPWpGaD
Furosemide—CA4—Metabolism—TSHB—hypothyroidism	7.15e-05	0.00199	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	6.98e-05	0.00194	CbGpPWpGaD
Furosemide—CA2—Metabolism—TSHB—hypothyroidism	6.86e-05	0.00191	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—AVP—hypothyroidism	6.85e-05	0.00191	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC5A5—hypothyroidism	6.71e-05	0.00187	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.64e-05	0.00185	CbGpPWpGaD
Furosemide—CA1—Metabolism—TSHB—hypothyroidism	6.57e-05	0.00183	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3C2A—hypothyroidism	6.37e-05	0.00177	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3C2A—hypothyroidism	6.11e-05	0.0017	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.97e-05	0.00166	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3C2A—hypothyroidism	5.86e-05	0.00163	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—AVP—hypothyroidism	5.78e-05	0.00161	CbGpPWpGaD
Furosemide—CA9—Metabolism—TSHB—hypothyroidism	5.78e-05	0.00161	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.67e-05	0.00158	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.54e-05	0.00154	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.37e-05	0.00149	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC5A5—hypothyroidism	5.35e-05	0.00149	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	5.28e-05	0.00147	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—AVP—hypothyroidism	5.23e-05	0.00145	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3C2A—hypothyroidism	5.15e-05	0.00143	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC5A5—hypothyroidism	5.13e-05	0.00143	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC5A5—hypothyroidism	4.92e-05	0.00137	CbGpPWpGaD
Furosemide—ALB—Metabolism—IYD—hypothyroidism	4.87e-05	0.00135	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.46e-05	0.00124	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	4.36e-05	0.00121	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC5A5—hypothyroidism	4.33e-05	0.0012	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.23e-05	0.00117	CbGpPWpGaD
Furosemide—CA14—Metabolism—POMC—hypothyroidism	4.17e-05	0.00116	CbGpPWpGaD
Furosemide—ALB—Metabolism—ATP5O—hypothyroidism	4.14e-05	0.00115	CbGpPWpGaD
Furosemide—CA5A—Metabolism—POMC—hypothyroidism	4.06e-05	0.00113	CbGpPWpGaD
Furosemide—CA6—Metabolism—POMC—hypothyroidism	4.06e-05	0.00113	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SH2B3—hypothyroidism	3.96e-05	0.0011	CbGpPWpGaD
Furosemide—PGD—Metabolism—POMC—hypothyroidism	3.92e-05	0.00109	CbGpPWpGaD
Furosemide—ALB—Metabolism—TPO—hypothyroidism	3.89e-05	0.00108	CbGpPWpGaD
Furosemide—CA7—Metabolism—POMC—hypothyroidism	3.79e-05	0.00105	CbGpPWpGaD
Furosemide—CA5B—Metabolism—POMC—hypothyroidism	3.79e-05	0.00105	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.61e-05	0.001	CbGpPWpGaD
Furosemide—CA12—Metabolism—POMC—hypothyroidism	3.51e-05	0.000976	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.25e-05	0.000903	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.88e-05	0.000801	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—hypothyroidism	2.8e-05	0.000779	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VAV3—hypothyroidism	2.72e-05	0.000756	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—hypothyroidism	2.69e-05	0.000746	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—hypothyroidism	2.57e-05	0.000716	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	2.27e-05	0.00063	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—hypothyroidism	2.26e-05	0.000629	CbGpPWpGaD
Furosemide—ALB—Metabolism—TSHB—hypothyroidism	1.8e-05	0.000501	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—hypothyroidism	1.67e-05	0.000465	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3C2A—hypothyroidism	1.61e-05	0.000446	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.59e-05	0.000441	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A5—hypothyroidism	1.35e-05	0.000375	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—hypothyroidism	7.06e-06	0.000196	CbGpPWpGaD
